http://rdf.ncbi.nlm.nih.gov/pubchem/patent/BR-102019014871-A2
Outgoing Links
| Predicate | Object |
|---|---|
| assignee | http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_778daa35b87ea726a59b1581fa51552a |
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-92 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-92 |
| filingDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor | http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_699aa65aeb570fb1828004491b9a3fe0 |
| publicationDate | 2022-02-15-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | BR-102019014871-A2 |
| titleOfInvention | Conjugated procedure of immunoenzimatic tests associated with aging based on the syndocanabinoid deficiency syndrome having as analyzing the biomarkoandocanabinoid lipoxin A4 in association with tests functional and neurological changes in obtaining the mapping of the vulnerability of the human organism for the development of neurodegenerative, neurological and inflammatory diseases |
| abstract | "Conjugate procedure of immunoenzymatic tests associated with aging based on endocanabinoid deficiency syndrome having as analyzing the Endocanabi-Noide Lipoxin Biomarker A4 in association with functional tests of neurological changes in the mapping of the vulnerability of the human organism for the development of neurodegenerative, neurological diseases AND INFLAMMATORY" represented by an inventive solution in the health area, notably in the pharmacology sector of the endocannabinoid system, finding particular application in the diagnosis of vulnerability of individuals regarding the involvement of neurological, neurodegenerative, inflammatory diseases when associated with the aging factor, being a distinctive procedure for conjugating immunoenzymatic tests having Lipoxin A4 as a biomarker with functional tests of neurological alterations, both associated with aging, converging on a mapping of the vulnerability of individuals to a d disease of interest, where the sample of individuals of interest has its individuals identified as: protected, at risk, vulnerable with developed pathology and undefined. |
| priorityDate | 2019-07-18-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 19.